摘要
No AccessJournal of UrologyJU Forum3 Sep 2024Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK Neal D. Shore, Ugo De Giorgi, and Stephen J. Freedland Neal D. ShoreNeal D. Shore Corresponding Author: Neal D. Shore, MD, FACS, Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC 29572 ( ([email protected]) ). https://orcid.org/0000-0001-5767-0548 , Ugo De GiorgiUgo De Giorgi Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy , and Stephen J. FreedlandStephen J. Freedland Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California The Durham VA Medical Center, Durham, North Carolina View All Author Informationhttps://doi.org/10.1097/JU.0000000000004228AboutPDF Cite Export CitationSelect Citation formatNLMAMAIEEEACMAPAChicagoMLAHarvardTips on citation downloadDownload citationCopy citation ToolsAdd to favoritesTrack Citations ShareFacebookLinked InTwitterEmail © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.KeywordsenzalutamideEMBARKhigh-risk biochemical recurrenceprostate cancerMetrics Author Information Neal D. Shore Corresponding Author: Neal D. Shore, MD, FACS, Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC 29572 ( ([email protected]) ). More articles by this author Ugo De Giorgi Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy More articles by this author Stephen J. Freedland Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California The Durham VA Medical Center, Durham, North Carolina More articles by this author Expand All Advertisement PDF downloadLoading ...